Life Science Webinar Series: Future-proofing your life science business

Life Science Webinar Series: Future-proofing your life science business

Webinar 1: Future-proofing your life science business

Thursday 2 December 2021
4:00pm – 5.00pm UK time (10.00am – 11.00am CT)

The life science sector is being transformed. Technology is reaching into every aspect of healthcare, blurring the boundaries between tech and medicine. Digitalisation has accelerated, opening up opportunities in areas such as telemedicine and home care devices.

The revolution in gene and cell research continues to bring forward exciting new therapies, while the pandemic triggered the fastest vaccine approval in history. 

Within this changing landscape new risks are emerging – from supply chain vulnerabilities to increased cyber and data threats – which have left insurance markets playing catch up.  

Understanding the new risk landscape
This webinar looks at these and other trends shaping the sector’s future. Our experts will help you navigate the changing risk landscape and take advantage of the exciting opportunities that lay ahead.  

During this session, we will cover:

  • The convergence of technology and medicine and what this means for insurance cover and liability, including latest case law  
  • Why is product liability changing 
  • How the rise of new medical technologies is increasing risks for companies 
  • How technology is changing the way clinical trials are conducted 
  • The ongoing rise of cell and gene therapies and how to mitigate the risks involved 

After this session, you will be able to:

  • Form a clearer picture of the emerging life science risk landscape
  • Understand how you can achieve the best outcome in a hard insurance marketplace 
  • Ensure that the scope of insurance coverage purchased reflects the changing risk landscape

Who is this webinar targeted for:
Global pharmaceutical and biotech companies. Anyone in these industries with an interest in risk management and/or responsibility for insurance purchase, from research and development (R&D) to manufacturing, drugs to medical devices including legal, finance and operational teams.

 

    Outlook Outlook
    iCal iCal
    Google Google
    Yahoo! Yahoo!
    MSN MSN
    Top